Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer

PURPOSE: Androgen receptor splice variant 7 (AR-V7) detection in circulating tumor cells (CTCs) is associated with a low probability of response and short progression-free (PFS) and overall survival (OS) in men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide or...

Descripción completa

Detalles Bibliográficos
Autores principales: Armstrong, Andrew J., Luo, Jun, Nanus, David M., Giannakakou, Paraskevi, Szmulewitz, Russell Z., Danila, Daniel C., Healy, Patrick, Anand, Monika, Berry, William R., Zhang, Tian, Harrison, Michael R., Lu, Changxue, Chen, Yan, Galletti, Giuseppe, Schonhoft, Joseph D., Scher, Howard I., Wenstrup, Richard, Tagawa, Scott T., Antonarakis, Emmanuel S., George, Daniel J., Halabi, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608579/
https://www.ncbi.nlm.nih.gov/pubmed/33154984
http://dx.doi.org/10.1200/PO.20.00200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608579/
https://www.ncbi.nlm.nih.gov/pubmed/33154984
http://dx.doi.org/10.1200/PO.20.00200

Ejemplares similares